Next Article in Journal
Clinical Significance of Serum Biomarkers in Pediatric Solid Mediastinal and Abdominal Tumors
Previous Article in Journal
Local Mechanical Stimulation of Mardin-Darby Canine Kidney Cell Sheets on Temperature-Responsive Hydrogel
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2012, 13(1), 1109-1125; doi:10.3390/ijms13011109

The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior

1
Departments of Neurosurgery, The First Affiliated Hospital of China Medical University, 155 Nanjingbei Street, Heping District, Shenyang 110001, China
2
School of Materials and Metallurgy, Northeastern University, No.11, Lane 3, WenHua Road, HePing District, Shenyang 110819, China
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Received: 7 November 2011 / Revised: 20 December 2011 / Accepted: 11 January 2012 / Published: 19 January 2012
(This article belongs to the Section Material Sciences and Nanotechnology)
View Full-Text   |   Download PDF [1891 KB, uploaded 19 June 2014]   |  

Abstract

In this study, we investigated the effects of temozolomide (TMZ)/Poly (lactide-co-glycolide)(PLGA)/nano-hydroxyapatite microspheres on the behavior of U87 glioma cells. The microspheres were fabricated by the “Solid/Water/Oil” method, and they were characterized by using X-Ray diffraction, scanning electron microscopy and differential scanning calorimetry. The proliferation, apoptosis and invasion of glioma cells were evaluated by MTT, flow cytometry assay and Transwell assay. The presence of the key invasive gene, αVβ3 integrin, was detected by the RT-PCR and Western blot method. It was found that the temozolomide/PLGA/nano-hydroxyapatite microspheres have a significantly diminished initial burst of drug release, compared to the TMZ laden PLGA microspheres. Our results suggest they can significantly inhibit the proliferation and invasion of glioma cells, and induce their apoptosis. Additionally, αVβ3 integrin was also reduced by the microspheres. These data suggest that by inhibiting the biological behavior of glioma cells in vitro, the newly designed temozolomide/PLGA/nano-hydroxyapatite microspheres, as controlled drug release carriers, have promising potential in treating glioma. View Full-Text
Keywords: controlled release; glioma; hydroxyapatite; Poly (lactide-co-glycolide) PLGA; temozolomide (TMZ) controlled release; glioma; hydroxyapatite; Poly (lactide-co-glycolide) PLGA; temozolomide (TMZ)
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zhang, D.; Tian, A.; Xue, X.; Wang, M.; Qiu, B.; Wu, A. The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior. Int. J. Mol. Sci. 2012, 13, 1109-1125.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top